
Maged Costantine
Division Director, Maternal Fetal Medicine · Ohio State University Hospital
Credentials: · · · · ·
History
PresentObstetrics and Gynecology · Ohio State University Hospital
- Present
Obstetrics and Gynecology Department · The Ohio State University

- 2016–2020
- 2007–2010
American University of Beruit
- 2004–2007
The University Hospital-Cincinnati
- 2003–2004
- 2001–2004
Research
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
JAMA · 2023 · 730 citations
Physiologic and pharmacokinetic changes in pregnancy
Review · Frontiers in Pharmacology · 2014 · Sole author · 352 citations
Obstetrics and Gynecology · 2021 · 301 citations

113 papers
- DR
61 papers

54 papers

49 papers

43 papers

41 papers
- UR
41 papers
- GH
37 papers
Grants
- 1992–2030
NICHD Maternal Fetal Medicine Units Network
National Institute of Child Health and Human Development · UG1
Contact PI · $2.5M · Ohio State University
- 2023–2028
National Institute of Child Health and Human Development · R24
Contact PI · $3.8M · Ohio State University
- 2019–2024
1/2 A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High-Risk Women
National Heart, Lung, and Blood Institute · UH3
Contact PI · $366.1K · Ohio State University
- 2021
Center for Development of Medications and Biologics for Treatment of the Pregnant Patient and Fetus
National Institute of Child Health and Human Development · U54
Project lead · $1.2M · University of Texas Med Br Galveston
Clinical trials
- 2024–2030
Principal investigator · Recruiting · Phase 4
Ohio State University
- 2024–2028
EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)
Principal investigator · Recruiting
Ohio State University
- 2021–2022
Principal investigator · Completed
Ohio State University
- 2019–2024
Pravastatin to Prevent Preeclampsia
Principal investigator · Terminated · Phase 3
The George Washington University Biostatistics Center


